Navigation Links
Cellular Dynamics International Announces Launch of Initial Public Offering
Date:7/10/2013

MADISON, Wis., July 10, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc., a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that it has commenced an initial public offering of 3,846,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission ("SEC").  In addition, the underwriters will have a 30-day option to purchase up to an additional 576,900 shares of common stock from the Company. The initial public offering price is currently expected to be between $12.00 and $14.00 per share of common stock.

The Company intends to use the net proceeds that it receives in the offering for research and product development activities; sales and marketing activities, including expansion of its sales force to support the ongoing commercialization of its products; property, plant and equipment, including the build-out of its laboratory in California, and intellectual property; and for working capital and other general corporate purposes.

J.P. Morgan Securities LLC is acting as sole book-running manager for the offering, and Cowen and Company, LLC and Leerink Swann LLC are acting as co-managers.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. Copie
'/>"/>

SOURCE Cellular Dynamics International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
2. Cellular Therapy and Cord Blood 2013 Market Report
3. Cellular Biomedicine Group Announces Appointment of Corporate Controller
4. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
5. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
6. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
7. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
8. Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
9. Exit discovered in cellular garbage truck
10. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
11. Cellular Biomedicine Group Provides Update and 2013 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 , ... Club, 1360 Almshouse Road, Warrington, Pa. , Details: ... dedicated to finding a cure for hepatitis B and improving ... its annual Crystal Ball on Friday, April 11 at Warrington ...
(Date:1/14/2014)... As pet owners drew up their lists of New Year,s resolutions ... care of my furry companion." Nowadays there are pet salons, dog ... to take the little canine or feline darlings along wherever mommy ... some pricey toys at the pet store. But anyone who has ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
(Date:1/14/2014)... 14, 2014   Kinaxis ®, provider of RapidResponse ®, ... and operations planning ( S&OP ) service, is proud to ... which will be held at the Hilton San Diego Bayfront, ... customer Elisabeth Kaszas , Director of Supply Chain at ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... June 8 CSL Limited (ASX: CSL) and Talecris Biotherapeutics, ... their merger agreement, announced on August 12, 2008, under which ... , , Dr. Brian McNamee, CEO and Managing Director ... Federal Trade Commission (FTC) resolved to block the transaction. ...
... Calif., June 8 Proteolix, Inc. today announced data from ... for the treatment of multiple myeloma at the 14th Congress ... Carfilzomib is the first in a new class of selective, ... of hematologic malignancies and solid tumors. , ...
... 8 /PRNewswire/ -- Pasteuria Bioscience announced that ... Agency (EPA) for Pasteuria usgae . This is ... spp., a natural bacteria prevalent in soil that have ... nematodes. , , "We,re very pleased to ...
Cached Biology Technology:CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 2CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 2Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 4Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 5Pasteuria Bioscience Receives EPA Registration for Nematode Control 2
(Date:4/23/2014)... Like a hungry diner ripping open a dinner roll, ... must tear open a hydrogen molecule. Now researchers have ... the two halves of its hydrogen feast. The view ... make the catalyst work better for alternative energy uses. ... shown precisely where the hydrogen halves end up in ...
(Date:4/23/2014)... 23 2014) A team of researchers ... (hNSCs) into the brains of nonhuman primates and ... 24 months found that the hNSCs had differentiated ... cause tumors. , The study will be published ... but is currently freely available on-line as ...
(Date:4/23/2014)... have found evidence of an interaction between prenatal ... behavior in children, especially in girls. , "The ... to prenatal smoking will have behavioral problems. ... Boutwell, Assistant Professor at Sam Houston State University, ... the study. "One possible explanation for this ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
... head. What do you do? You probably first move out of ... object is. Your brain is able to quickly switch from detecting ... is through a phenomenon called adaptation. A new study in ... Neuroscience details the biological basis of this ability for rapid ...
... , WASHINGTON, D.C., November 21, 2010 -- Jump ropes are ... But what about the underlying physics? How do jump ropes ... Aristoff and Howard Stone of Princeton University have built themselves ... parameters -- rope rotation rate, rope density, diameter, length, and ...
... The Innovative Vector Control Consortium (IVCC) has received $50 ... continue its work to develop new insecticides for the ... malaria, dengue and other neglected tropical diseases. ... grant of $50.7 million over five years from the ...
Cached Biology News:Study reveals neural basis of rapid brain adaptation 2Study reveals neural basis of rapid brain adaptation 3
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
Biology Products: